FDA grants approval to Eli Lilly for alopecia drug

The U.S. Food and Drug Administration on Monday granted approval to Olumiant, an alopecia treatment developed by Eli Lilly that produced hair regrowth in trials.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news